Warning: Undefined array key "mm" in /www/wwwroot/www.ai-bt.com/si.php on line 10 Deprecated: trim(): Passing null to parameter #1 ($string) of type string is deprecated in /www/wwwroot/www.ai-bt.com/si.php on line 10 Message in a bottle from the tumor microenvironment: tumor-educated DCs instruct B cells to participate in immunosuppression.

Literature DB >> 28757609

Message in a bottle from the tumor microenvironment: tumor-educated DCs instruct B cells to participate in immunosuppression.

Francesca Mion¹, Silvia Tonon¹, Viviana Valeri¹, Carlo E Pucillo¹.

Abstract

Entities: Disease

Mesh：

Substances：
Interleukin-10

Year: 2017 PMID： 28757609 PMCID： PMC5596249 DOI： 10.1038/cmi.2017.63

Source DB: PubMed Journal: Cell Mol Immunol ISSN： 1672-7681 Impact factor: 11.530

× No keyword cloud information.

15 in total

1. Chronic intestinal inflammatory condition generates IL-10-producing regulatory B cell subset characterized by CD1d upregulation.

Authors: Atsushi Mizoguchi; Emiko Mizoguchi; Hidetoshi Takedatsu; Richard S Blumberg; Atul K Bhan
Journal: Immunity Date: 2002-02 Impact factor: 31.745

2. Regulatory dendritic cells program B cells to differentiate into CD19hiFcγIIbhi regulatory B cells through IFN-β and CD40L.

Authors: Li Qian; Cheng Qian; Yongjian Chen; Yi Bai; Yan Bao; Liwei Lu; Xuetao Cao
Journal: Blood Date: 2012-06-12 Impact factor: 22.113

Review 3. Regulatory B cells: origin, phenotype, and function.

Authors: Elizabeth C Rosser; Claudia Mauri
Journal: Immunity Date: 2015-04-21 Impact factor: 31.745

4. Mast cells control the expansion and differentiation of IL-10-competent B cells.

Authors: Francesca Mion; Federica D'Incà; Luca Danelli; Barbara Toffoletto; Carla Guarnotta; Barbara Frossi; Alessia Burocchi; Alice Rigoni; Norbert Gerdes; Esther Lutgens; Claudio Tripodo; Mario P Colombo; Juan Rivera; Gaetano Vitale; Carlo E Pucillo
Journal: J Immunol Date: 2014-09-29 Impact factor: 5.422

5. IL35-Producing B Cells Promote the Development of Pancreatic Neoplasia.

Authors: Yuliya Pylayeva-Gupta; Shipra Das; Jesse S Handler; Cristina H Hajdu; Maryaline Coffre; Sergei B Koralov; Dafna Bar-Sagi
Journal: Cancer Discov Date: 2015-12-29 Impact factor: 39.397

Review 6. Targeting the Fas/FasL signaling pathway in cancer therapy.

Authors: María Villa-Morales; José Fernández-Piqueras
Journal: Expert Opin Ther Targets Date: 2012-01-12 Impact factor: 6.902

7. Tumor-educated tolerogenic dendritic cells induce CD3epsilon down-regulation and apoptosis of T cells through oxygen-dependent pathways.

Authors: Dong-Ming Kuang; Qiyi Zhao; Jing Xu; Jing-Ping Yun; Changyou Wu; Limin Zheng
Journal: J Immunol Date: 2008-09-01 Impact factor: 5.422

3. Low-dose decitabine enhances the effect of PD-1 blockade in colorectal cancer with microsatellite stability by re-modulating the tumor microenvironment.

Authors: Ganjun Yu; Yanfeng Wu; Wenying Wang; Jia Xu; Xiaoping Lv; Xuetao Cao; Tao Wan
Journal: Cell Mol Immunol Date: 2018-04-05 Impact factor: 11.530

3 in total

Message in a bottle from the tumor microenvironment: tumor-educated DCs instruct B cells to participate in immunosuppression.

1. Chronic intestinal inflammatory condition generates IL-10-producing regulatory B cell subset characterized by CD1d upregulation.

2. Regulatory dendritic cells program B cells to differentiate into CD19hiFcγIIbhi regulatory B cells through IFN-β and CD40L.

Review 3. Regulatory B cells: origin, phenotype, and function.

4. Mast cells control the expansion and differentiation of IL-10-competent B cells.

5. IL35-Producing B Cells Promote the Development of Pancreatic Neoplasia.

Review 6. Targeting the Fas/FasL signaling pathway in cancer therapy.

7. Tumor-educated tolerogenic dendritic cells induce CD3epsilon down-regulation and apoptosis of T cells through oxygen-dependent pathways.

8. Regulatory B cells preferentially accumulate in tumor-draining lymph nodes and promote tumor growth.

Review 9. B cell regulation of the anti-tumor response and role in carcinogenesis.

10. Dendritic cell-elicited B-cell activation fosters immune privilege via IL-10 signals in hepatocellular carcinoma.

Review 1. Tumor-infiltrating B cells: their role and application in anti-tumor immunity in lung cancer.

2. An Overview of Advances in Cell-Based Cancer Immunotherapies Based on the Multiple Immune-Cancer Cell Interactions.

3. Low-dose decitabine enhances the effect of PD-1 blockade in colorectal cancer with microsatellite stability by re-modulating the tumor microenvironment.